11. A comparative safety review of histone deacetylase inhibitors for the treatment of myeloma. Issue 7 (3rd July 2019) Authors: Cengiz Seval, Guldane; Beksac, Meral Journal: Expert opinion on drug safety Issue: Volume 18:Issue 7(2019) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. A comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) database. Issue 6 (3rd June 2018) Authors: Dagenais, Simon; Scranton, Richard; Joyce, Andrew R.; Vick, Catherine C. Journal: Expert opinion on drug safety Issue: Volume 17:Issue 6(2018) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China. (July 2014) Authors: Hou, Yongfang; Ye, Xiaofei; Wu, Guizhi; Cheng, Gang; Du, Xiaoxi; He, Jia Journal: Expert opinion on drug safety Issue: Volume 13:Number 7(2014) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China. (July 2014) Authors: Hou, Yongfang; Ye, Xiaofei; Wu, Guizhi; Cheng, Gang; Du, Xiaoxi; He, Jia Journal: Expert opinion on drug safety Issue: Volume 13:Number 7(2014) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. A comparison of pregnancy prevention programmes in Europe. (April 2014) Authors: Crijns, Ineke; Zomerdijk, Inge; Sturkenboom, Miriam; de Jong-van den Berg, Lolkje; Straus, Sabine Journal: Expert opinion on drug safety Issue: Volume 13:Number 4(2014:Jul.) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. A comparison of pregnancy prevention programmes in Europe. (April 2014) Authors: Crijns, Ineke; Zomerdijk, Inge; Sturkenboom, Miriam; de Jong-van den Berg, Lolkje; Straus, Sabine Journal: Expert opinion on drug safety Issue: Volume 13:Number 4(2014:Jul.) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression. Issue 6 (3rd June 2022) Authors: Tamman, Amanda; Anand, Amit; Mathew, Sanjay J. Journal: Expert opinion on drug safety Issue: Volume 21:Issue 6(2022) Page Start: 745 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. A complicated role for the renin–angiotensin system during pregnancy: highlighting the importance of drug discovery. (November 2013) Authors: Darby, Marie; Martin, James N; LaMarca, Babbette Journal: Expert opinion on drug safety Issue: Volume 12:Number 6(2013:Nov.) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. A comprehensive overview and safety evaluation of fremanezumab as a preventive therapy for migraine. Issue 5 (3rd May 2020) Authors: Parikh, Simy K.; Burkett, John G.; Silberstein, Stephen D. Journal: Expert opinion on drug safety Issue: Volume 19:Issue 5(2020) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis. (July 2015) Authors: D'Amico, Emanuele; Messina, Silvia; Caserta, Cinzia; Patti, Francesco Journal: Expert opinion on drug safety Issue: Volume 14:Number 7(2015) Page Start: 1157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗